Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kim Robert Young
Chief Medical Officer at 4D Molecular Therapeutics. Filing since 5 Feb 2024.
CIK 0001971608
Company
Date
Role
Action
Shares
Amount
Of holding
FDMT
4D Molecular Therapeutics, Inc.
5 Feb 2024
Chief Medical Officer
Sold on a plan
24,552
$737.79K
95.9%
1 decision on file.